Cargando…

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma

Lung adenocarcinoma (LUAD) remains the most common subtype of lung malignancy. Cuproptosis is a newly identified cell death which could regulate tumor cell proliferation and progression. Long non-coding RNAs (lncRNAs) are key molecules and potential biomarkers for diagnosing and treating various dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Xiaocong, Hu, Di, Yang, Pingshan, Li, Yin, Bashir, Shoaib, Nai, Aitao, Ma, Feng, Jia, Guoxia, Xu, Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353736/ https://www.ncbi.nlm.nih.gov/pubmed/35936736 http://dx.doi.org/10.3389/fonc.2022.927706

Ejemplares similares

MIR31HG, a potential lncRNA in human cancers and non-cancers
por: Ruan, Luxi, et al.
Publicado: (2023)

Knockdown of lncRNA MIR31HG inhibits cell proliferation in human HaCaT keratinocytes
por: Gao, Jintao, et al.
Publicado: (2018)

Co-upregulation of miR-31 and its host gene lncRNA MIR31HG in oral squamous cell carcinoma
por: Tu, Hsi-Feng, et al.
Publicado: (2022)

The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors
por: Tu, Chao, et al.
Publicado: (2020)

Polymorphisms in lncRNA MIR2052HG and susceptibility to breast cancer in Chinese population
por: Yang, Hui, et al.
Publicado: (2021)

LncRNA MIR31HG controls the proliferation and metastasis of gastric cancer by c-CBL-mediated degradation of β-catenin
por: Peng, Wen, et al.
Publicado: (2023)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer
por: Li, Jun, et al.
Publicado: (2019)

LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer
por: Müller, Volkmar, et al.
Publicado: (2019)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

LncRNA MIR31HG Drives Oncogenicity by Inhibiting the Limb-Bud and Heart Development Gene (LBH) during Oral Carcinoma
por: Chang, Kuo-Wei, et al.
Publicado: (2021)

LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis
por: Guo, Jinlan, et al.
Publicado: (2021)

lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer
por: Nai, Aitao, et al.
Publicado: (2022)

LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis
por: Xiao, Yu, et al.
Publicado: (2019)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
por: Zhang, Liming, et al.
Publicado: (2023)

LncRNA NEAT1 mediates intestinal inflammation by regulating TNFRSF1B
por: Pan, Shiyu, et al.
Publicado: (2021)

LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR‐193a‐3p
por: Yu, Hong‐Mei, et al.
Publicado: (2018)

LncRNA MIR4435-2HG inhibits the progression of osteoarthritis through miR-510-3p sponging
por: Liu, Yingli, et al.
Publicado: (2020)

Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy
por: Ho, Kuo‐Hao, et al.
Publicado: (2021)

Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
por: Chen, Zhou, et al.
Publicado: (2023)

Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
por: Wang, Fangwei, et al.
Publicado: (2022)

The lncRNA Toolkit: Databases and In Silico Tools for lncRNA Analysis
por: Pinkney, Holly R., et al.
Publicado: (2020)

Knockdown of lncRNA MIR31HG inhibits adipocyte differentiation of human adipose-derived stem cells via histone modification of FABP4
por: Huang, Yiping, et al.
Publicado: (2017)

LncRNA miR143HG Up-Regulates p53 In Endometrial Carcinoma By Sponging miR-125a
por: Shi, Fan, et al.
Publicado: (2019)

LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer
por: Zhu, Ding, et al.
Publicado: (2020)

A micropeptide encoded by lncRNA MIR155HG suppresses autoimmune inflammation via modulating antigen presentation
por: Niu, Liman, et al.
Publicado: (2020)

LncRNA miR205HG hinders HNRNPA0 translation: anti‐oncogenic effects in esophageal carcinoma
por: Dong, Xiaoying, et al.
Publicado: (2021)

LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer
por: Xu, Yaqian, et al.
Publicado: (2021)

Protective effect of hepatocyte-enriched lncRNA-Mir122hg by promoting hepatocyte proliferation in acute liver injury
por: Yu, Zhenjun, et al.
Publicado: (2022)

Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer
por: Wu, Jia-hao, et al.
Publicado: (2023)

LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis
por: Li, Hongle, et al.
Publicado: (2020)

LncRNA MIR22HG promotes osteoarthritis progression via regulating miR-9-3p/ADAMTS5 pathway
por: Long, Hui, et al.
Publicado: (2021)

Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling
por: Li, Huihui, et al.
Publicado: (2019)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer
por: Xu, Qiushi, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
por: Zhu, Yidong, et al.
Publicado: (2023)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
por: Pang, Lin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i1k0f2ade83np8j6lm2okh8kkp